My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Detection of somatostatin receptors in human osteosarcoma.

    Ioannou M, Papagelopoulos PJ, Papanastassiou I, Iakovidou I, Kottakis S, Demertzis N.

    World J Surg Oncol. 2008 Sep 10;6:99.PMID: 18783595 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.

    Dalla-Torre CA, Yoshimoto M, Lee CH, Joshua AM, de Toledo SR, Petrilli AS, Andrade JA, Chilton-MacNeill S, Zielenska M, Squire JA.

    BMC Cancer. 2006 Oct 5;6:237.PMID: 17022822 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.

    Ferrari S, Zanella L, Alberghini M, Palmerini E, Staals E, Bacchini P.

    Pediatr Blood Cancer. 2008 Apr;50(4):752-6.PMID: 17886294 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ezrin expression predicts survival in stage IIB osteosarcomas.

    Kim MS, Song WS, Cho WH, Lee SY, Jeon DG.

    Clin Orthop Relat Res. 2007 Jun;459:229-36.PMID: 17353802 [PubMed - indexed for MEDLINE]Related articles

    5.

    Vascular endothelial growth factor expression in osteosarcoma.

    Charity RM, Foukas AF, Deshmukh NS, Grimer RJ.

    Clin Orthop Relat Res. 2006 Jul;448:193-8.PMID: 16826116 [PubMed - indexed for MEDLINE]Related articles

    6.

    Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.

    Foukas AF, Deshmukh NS, Grimer RJ, Mangham DC, Mangos EG, Taylor S.

    J Bone Joint Surg Br. 2002 Jul;84(5):706-11.PMID: 12188489 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker.

    Sulzbacher I, Birner P, Toma C, Wick N, Mazal PR.

    J Clin Pathol. 2007 Jul;60(7):804-7. Epub 2006 Oct 3.PMID: 17018686 [PubMed - indexed for MEDLINE]Related articles

    8.

    The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter.

    Sulzbacher I, Birner P, Trieb K, Pichlbauer E, Lang S.

    J Clin Pathol. 2002 May;55(5):381-5.PMID: 11986346 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.

    Abdeen A, Chou AJ, Healey JH, Khanna C, Osborne TS, Hewitt SM, Kim M, Wang D, Moody K, Gorlick R.

    Cancer. 2009 Nov 15;115(22):5243-50.PMID: 19670450 [PubMed - indexed for MEDLINE]Related articles

    10.

    Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues.

    Ressler S, Radhi J, Aigner T, Loo C, Zwerschke W, Sergi C.

    Anticancer Res. 2009 Jul;29(7):2579-87.PMID: 19596932 [PubMed - indexed for MEDLINE]Related articles

    11.

    [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis]

    Ozger H, Eralp L, Atalar AC, Toker B, Esberk Ateş L, Sungur M, Bilgiç B, Ayan I.

    Acta Orthop Traumatol Turc. 2009 Jan-Feb;43(1):28-34. Turkish. PMID: 19293613 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CD9 expression is not a prognostic factor in human osteosarcoma.

    Kubista B, Erovic BM, Klinger H, Sulzbacher I, Trieb K.

    Cancer Lett. 2004 Jun 8;209(1):105-10.PMID: 15145525 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prognostic and predictive value of c-erbB2 overexpression in osteogenic sarcoma.

    Rakesh Kumar V, Gupta N, Kakkar N, Sharma SC.

    J Cancer Res Ther. 2006 Jan-Mar;2(1):20-3.PMID: 17998668 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma.

    Ferrari S, Dondi M, Fanti S, Zoboli S, Giacomini S, Mercuri M, Bacci G.

    Cancer Biother Radiopharm. 2003 Oct;18(5):847-51.PMID: 14629833 [PubMed - indexed for MEDLINE]Related articles

    15.

    Down-regulation of ribosomal protein L7A in human osteosarcoma.

    Zheng SE, Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Sun YJ, Tang LN.

    J Cancer Res Clin Oncol. 2009 Aug;135(8):1025-31. Epub 2009 Jan 6.PMID: 19125294 [PubMed - indexed for MEDLINE]Related articles

    16.

    Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies.

    Srirajaskanthan R, Watkins J, Marelli L, Khan K, Caplin ME.

    Neuroendocrinology. 2009;89(3):308-14. Epub 2009 Mar 23.PMID: 19307732 [PubMed - indexed for MEDLINE]Related articles

    17.

    Immunohistochemical profile of ephrin A4 expression in human osteosarcoma.

    Abdou AG, Abd El-Wahed MM, Asaad NY, Samaka RM, Abdallaha R.

    APMIS. 2009 Apr;117(4):277-85.PMID: 19338516 [PubMed - indexed for MEDLINE]Related articles

    18.

    The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.

    Huang J, Zhu B, Lu L, Lian Z, Wang Y, Yang X, Satiroglu-Tufan NL, Liu J, Luo Z.

    Pathology. 2009 Feb;41(2):149-54.PMID: 18972316 [PubMed - indexed for MEDLINE]Related articles

    19.

    The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.

    Do SI, Jung WW, Kim HS, Park YK.

    Int J Oncol. 2009 Mar;34(3):797-803.PMID: 19212684 [PubMed - indexed for MEDLINE]Related articles

    20.

    Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide.

    Takei M, Suzuki M, Kajiya H, Ishii Y, Tahara S, Miyakoshi T, Egashira N, Takekoshi S, Sanno N, Teramoto A, Osamura RY.

    Endocr Pathol. 2007 Winter;18(4):208-16.PMID: 17987403 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk